While the pandemic prevented a face-to-face event in 2020, the Bay Area Biotech-Pharma Statistical Workshop held two virtual symposiums—both related to COVID-19.
biostatistics
CHANCE Highlights: Issue Looks at Black History Month, Slot Machines, and Crowd Funding
The February issue of CHANCE includes an interview with Emery Brown, as well as articles on crowd-funding, slot machines, statistics education, and misattribution.
Pfizer/ASA/UConn Distinguished Statistician Colloquium Returns
Peter Bickel of the University of California, Berkeley will present “Four Excursions in Genomics” at the colloquium.
Data for Good Can Drive COVID Vaccine Confidence
David Corliss says statisticians can help address the distrust of vaccines, a large challenge of this phase of the COVID-19 pandemic.
Rebecca Hubbard
Rebecca Hubbard always excelled at science and math and considered becoming a science fiction writer but chose pre-med instead. However, not a “people person,” she discovered she had no interest in the clinical side of medicine. While looking for summer research opportunities, she learned about the Harvard Summer Program in Biostatistics, a field she had never heard of before, and decided to give it a try. This literally changed her life. Today, a professor at the University of Pennsylvania, she writes papers instead of poetry and science instead of fiction and helps her talented students decode the academic maze.
Virginia Tech Appoints Ronald D. Fricker as Interim Dean
Fricker joined Virginia Tech in 2015 as head of the department of statistics and most recently served as the senior associate dean in the college of science.
Gertrude M. Cox Award Nominations Sought
Nominate an early- to mid-career statistician for the Gertrude Cox Award by February 28.
People News for December 2020
Ruth Etzioni and Emery N. Brown were honored recently.
Biopharmaceutical Report Focuses on Statistical Issues in COVID-19 Trials
The editorial team invited authors from government, industry, and academia to write articles about their perspectives on the impact of COVID-19 on clinical trials, particularly the statistical issues involved in designing new COVID-19 trials.
An Interview with Margaret Gamalo, Editor of JBS
Gamalo talks about new initiatives for Journal of Biopharmaceutical Statistics, the future of scientific publishing, and the importance of curiosity for statisticians.